Intrinsic Value of S&P & Nasdaq Contact Us

Ardelyx, Inc. ARDX NASDAQ

NASDAQ Global Market • Healthcare • Biotechnology • US • USD

SharesGrow Score
52/100
2/7 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow
Analyst Price Target
$17.00
+168.6%
SharesGrow 7-Criteria Score All 7 criteria scored · valuation-related highlighted on this page

Ardelyx, Inc. (ARDX) has a negative trailing P/E of -23.7, meaning the company is currently unprofitable on a trailing twelve-month (TTM) basis. The forward P/E of 7,912.5 based on analyst estimates suggests a return to profitability is expected. Trailing earnings yield is -4.22%, forward earnings yield 0.01%. PEG 12.71.

Criteria proven by this page:

  • VALUE (78/100, Pass) — analyst target implies upside (+168.6%).
  • Forward P/E 7,912.5 — analysts expect a return to profitability with estimated EPS of $0.00 for FY2026.
  • PEG Ratio 12.71 — above 2.0 suggests expensive relative to earnings growth.
  • Trailing Earnings Yield -4.22% — negative yield confirms the company is currently unprofitable. Investors are paying for a turnaround rather than current earnings. Forward yield improves to 0.01% as earnings recover.
  • Analyst consensus target $17.00 (+168.6% upside) — significant upside potential according to Wall Street analysts.

Overall SharesGrow Score: 52/100 with 2/7 criteria passed.

SharesGrow 7-Criteria Score
52/100
SG Score
View full scorecard →
VALUE
78/100
Price-to-Earnings & upside
Proven by this page
FUTURE
100/100
Analyst consensus
→ Forecast
PAST
0/100
→ Income
~
HEALTH
50/100
Debt-to-Equity & liquidity
→ Health
~
MOAT
66/100
→ Income
~
GROWTH
58/100
→ Income
INCOME
10/100
→ Income

Valuation Snapshot — ARDX

Valuation Multiples
P/E (TTM)-23.7
Forward P/E7,912.5
PEG Ratio12.71
Forward PEG12.71
P/B Ratio8.73
P/S Ratio3.60
EV/EBITDA-55.2
Per Share Data
EPS (TTM)$-0.25
Forward EPS (Est.)$0.00
Book Value / Share$0.69
Revenue / Share$1.67
FCF / Share$-0.18
Yields & Fair Value
Earnings Yield-4.22%
Forward Earnings Yield0.01%
Dividend Yield0.00%
Analyst Target$17.00 (+168.6%)

Historical Valuation

Year P/E (TTM) PEG Ratio P/B Ratio P/S Ratio Dividend Yield
2016 -1.3 -0.01 0.74 5.93 -
2017 -1.2 0.02 0.56 1.86 -
2018 -0.3 -0.01 0.22 9.65 -
2019 -1.3 0.14 0.65 22.95 -
2020 -1.5 0.05 1.15 19.17 -
2021 -0.7 -0.02 1.39 11.35 -
2022 -6.7 0.09 4.60 8.67 -
2023 -20.6 0.72 8.15 10.93 -
2024 -30.5 0.70 6.88 3.57 -
2025 -22.8 -0.43 8.42 3.45 -

EPS: Actual vs Estimates

P/E Ratio & Earnings Yield

Earnings Per Share (EPS) History

Year EPS (Diluted) Revenue Net Income Net Margin
2016 $-2.80 $24.03M $-112.39M -467.8%
2017 $-1.36 $42M $-64.34M -153.2%
2018 $-1.62 $2.61M $-91.3M -3502%
2019 $-1.47 $5.28M $-94.94M -1797.8%
2020 $-1.05 $7.57M $-94.31M -1245.7%
2021 $-1.52 $10.1M $-158.17M -1566.5%
2022 $-0.42 $52.16M $-67.21M -128.9%
2023 $-0.30 $124.46M $-66.07M -53.1%
2024 $-0.17 $333.62M $-39.14M -11.7%
2025 $-0.26 $407.32M $-61.6M -15.1%

Analyst Estimates

Year EPS (Avg) EPS Range Revenue (Avg) Revenue Range Analysts
2026 $0.00 $-0.01 – $0.01 $550.07M $546.9M – $554.79M 8
2027 $0.51 $0.33 – $0.66 $738.44M $698.12M – $767.64M 7
2028 $1.18 $0.89 – $1.63 $979.18M $979.18M – $979.18M 7
2029 $1.78 $1.68 – $1.86 $1.24B $1.19B – $1.28B 2
2030 $2.18 $2.06 – $2.28 $1.4B $1.34B – $1.45B 5
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message